VITRAKVI
NDC 50419-392, LAROTRECTINIB, solution, concentrate, from Bayer HealthCare Pharmaceuticals Inc..
- Product NDC
- 50419-392
- Status
- Listed
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Dosage form
- SOLUTION, CONCENTRATE
- Route
- OROPHARYNGEAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211710
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50419-392 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAROTRECTINIB20 mg/mL
Pharmacologic classes
Kinase Inhibitor [EPC]; Tropomyosin Receptor Kinases Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50419-392-01 | 50419039201 | 100 mL in 1 BOTTLE (50419-392-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0c8ca614-58b2-4aa4-83d3-0387a8f782fd
Use it
Look up 50419-392 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50419-392 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50419-392. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.